Plaintiffs Lose Class Cert. Bid in Mo. Neurontin Case
A Missouri judge has denied class certification to plaintiffs who sued Pfizer Inc. arguing they overpaid to use epilepsy drug Neurontin for off-label purposes for which the drug was ineffective....To view the full article, register now.
Already a subscriber? Click here to view full article